Raiffeisen Bank International’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51K Hold
6
﹤0.01% 770
2026
Q1
$1.3K Hold
6
﹤0.01% 805
2025
Q4
$1.16K Hold
6
﹤0.01% 785
2025
Q3
$1.39K Buy
+6
New +$1.22K ﹤0.01% 790

Other funds holding ABBV

Raiffeisen Bank International's ABBV Position: Q2 2026 in Review

Raiffeisen Bank International increased its AbbVie (ABBV) stake by 2.6% in Q2 2026, buying an estimated $2.11M and bringing the position to 379,931 shares worth $96.6M. The position accounts for 1.13% of the portfolio, ranked #15.

Raiffeisen Bank International first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,974 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Raiffeisen Bank International held 379,931 shares of AbbVie worth $96.6M as of Q2 2026.
  • Raiffeisen Bank International bought 9,801 AbbVie shares in Q2 2026, an estimated $2.11M.
  • AbbVie made up 1.13% of Raiffeisen Bank International's portfolio in Q2 2026, its #15 holding.
  • Raiffeisen Bank International first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,974 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.